Adma Biologics ADMA
NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Adma Biologics (ADMA) Depreciation & Amortization (CF) (2011 - 2026)

Updated

Adma Biologics' Depreciation & Amortization (CF) was $1.79 million in Q3 2026, down 11.6% from $2.02 million a year earlier but up 0.4% from the prior quarter.

Analysis

Adma Biologics (ADMA) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Adma Biologics' Depreciation & Amortization (CF) was $7.46 million through Sep 30, 2026, down 6.7% year-over-year; for FY2025, it came in at $8.1 million, up 0.6% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $8.05 million in FY2024 (-3.4%), $8.33 million in FY2023 (+17.1%), $7.11 million in FY2022 (+29.4%) and $5.5 million in FY2021 (+39.4%).
  • Quarterly Depreciation & Amortization (CF) has moved between $1.52 million (Q4 2021) and $2.11 million (Q1 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for three straight quarters, with an average decline of 4.5% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2022 (growth of 30.9%); the worst was Q2 2026 (a decline of 13.5%).
  • Per Business Quant data, ADMA's Depreciation & Amortization (CF) in the three quarters before Q3 2026 was $1.78 million (Q2 2026), $1.84 million (Q1 2026) and $2.05 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.12 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 192.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 132.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 1.58 Bn
10 Adma Biologics 2.87 Bn 2.39 Bn 99.92 Mn 1.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.79 Mn
Jun 30, 2026 1.78 Mn
Mar 31, 2026 1.84 Mn
Dec 31, 2025 2.05 Mn
Sep 30, 2025 2.02 Mn
Jun 30, 2025 2.06 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2024 1.94 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 2.05 Mn
Mar 31, 2024 2.11 Mn
Dec 31, 2023 2.11 Mn
Sep 30, 2023 2.09 Mn
Jun 30, 2023 2.10 Mn
Mar 31, 2023 2.03 Mn
Dec 31, 2022 1.94 Mn
Sep 30, 2022 1.86 Mn
Jun 30, 2022 1.72 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 1.52 Mn
API Access

Adma Biologics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ADMA&period=max&api_key=YOUR_API_KEY